James Condulis
Stock Analyst at Stifel
(2.85)
# 1,752
Out of 4,944 analysts
5
Total ratings
75%
Success rate
20.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $25.76 | +70.81% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $81.14 | +33.10% | 2 | Mar 28, 2025 | |
| CYTK Cytokinetics | Initiates: Buy | $80 | $36.88 | +116.92% | 1 | Jan 22, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $13.73 | +118.50% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $25.76
Upside: +70.81%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $81.14
Upside: +33.10%
Cytokinetics
Jan 22, 2025
Initiates: Buy
Price Target: $80
Current: $36.88
Upside: +116.92%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $13.73
Upside: +118.50%